Antimicrobial Susceptibility Testing Market (Type - Antimicrobial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing, and Other Susceptibility Testing; Application - Clinical Diagnostics, Drug Discovery and Dev

Antimicrobial Susceptibility Testing Market (Type - Antimicrobial Susceptibility Testing, Antifungal Susceptibility Testing, Antiparasitic Susceptibility Testing, and Other Susceptibility Testing; Application - Clinical Diagnostics, Drug Discovery and Development, Epidemiology, and Other Applications; End User - Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research & Academic Institutes, and Clinical Research Organizations): Global Industry Analysis, Trends, Size, Share and Forecasts to 2030

The report on the global antimicrobial susceptibility testing market provides qualitative and quantitative analysis for the period from 2021-2030. The global antimicrobial susceptibility testing market was valued at USD 3545.8 million in 2022 and is expected to reach USD 5986.31 million in 2030, with a CAGR of 5.95% during the forecast period 2023-2030. The study on the antimicrobial susceptibility testing market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

Rigorous growth in the number of pathogenic diseases caused due to poor hygiene conditions and lack of sanitation has offered incremental growth opportunities for the antimicrobial susceptibility testing market. Overconsumption of antimicrobial drugs i.e. drug abuse has significantly strengthened the resistance of bacteria, fungi, and pathogens due to which the prevalence of ASTs has exceeded in the current scenario at clinical and research levels.

According to the National Institutes of Health, nearly 13% of the global population has died due to the occurrence of bacterial infections. The need for better and more effective therapeutic drugs for the treatment of microbe-borne infections and ailments will increase the use of AST for studying the resistance and efficacy of various ranges of antibodies and this factor is projected to stage rewarding growth prospects to the market during the forecast years.

The Clinical Diagnostics Segment is Expected to Dominate the Market

The global antimicrobial susceptibility testing market is bifurcated By Type, Application, and End User. By End User, the segment is further bifurcated into Hospitals and Diagnostic centers, Pharmaceutical and Biotechnology Companies, Research & Academic Institutes, and Clinical Research Organizations. The Clinical Diagnostics segment is anticipated to dominate the market growth during the forecast period.

In order for healthcare professionals to choose the best antibiotic therapy for patients with bacterial infections, antimicrobial susceptibility testing, or AST, is a crucial part of clinical diagnosis. As a result, patient care is enhanced, and infectious disease management is promoted more successfully. AST results help in directing treatment decisions, dose modifications, and the selection of substitute drugs when resistance is discovered. This has significantly increased the use of antimicrobial susceptibility testing in clinical diagnostics.

The North American Region is Anticipated to be Dominating Region in the Global Antimicrobial Susceptibility Testing Market

The global antimicrobial susceptibility testing market is segmented into the Asia Pacific, North America, Europe, the Middle East & Africa, and South America. North America is expected to dominate the global market and will attain a majority of the market share owing to rising government initiatives and expenditure in the development of public healthcare and associated sectors within the forecast years.

Moreover, increasing investment by regional and global manufacturers present in the region to develop novel and automated antimicrobial susceptibility testing kits and systems is staging growth opportunities for the product market. Moreover, the introduction of a variety of genomic and genetic characterization, and identification methods would further offer momentous growth opportunities for the market over the forecast years.

Report Findings

1) Drivers

Rigorous increase in chronic diseases caused due to the evolution of antibody resistance microbes have prevailed in the use of antimicrobial susceptibility testing.

Growing number of hospital-acquired infections and continuous rise in the number of patients across the globe, specifically in the developing economies, along with rising government initiatives to prevent the disease spread is propelling the AST market.

2) Restraints

Lack of awareness about the importance of antimicrobial susceptibility testing and its role in guiding appropriate antibiotic therapy is restraining the market.

3) Opportunities

Increasing demand for point-of-care testing and high-tech automated testing done by using AST cards and panels is expected to create lucrative growth opportunities for market growth.

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

1. Key Opinion Leaders associated with Infinium Global Research

2. Internal and External subject matter experts

3. Professionals and participants from the industry

Our primary research respondents typically include

1. Executives working with leading companies in the market under review

2. Product/brand/marketing managers

3. CXO level executives

4. Regional/zonal/ country managers

5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications

2. Government/institutional publications

3. Trade and associations journals

4. Databases such as WTO, OECD, World Bank, and among others.

5. Websites and publications by research agencies

Segment Covered

The global antimicrobial susceptibility testing market is segmented on the basis of type, application, and end user.

The Global Antimicrobial Susceptibility Testing Market by Type

Antimicrobial Susceptibility Testing

Antifungal Susceptibility Testing

Antiparasitic Susceptibility Testing

Other Susceptibility Testing

The Global Antimicrobial Susceptibility Testing Market by Application

Clinical Diagnostics

Drug Discovery and Development

Epidemiology

Other Applications

The Global Antimicrobial Susceptibility Testing Market by End User

Hospitals and Diagnostic Centers

Pharmaceutical and Biotechnology Companies

Research & Academic Institutes

Clinical Research Organizations

Company Profiles

The companies covered in the report include

Accelerate Diagnostics, Inc.

BD

BIOMÉRIEUX

Bruker

Bio-Rad Laboratories, Inc.

Creative Diagnostics

HiMedia Laboratories

Alifax S.r.l.

Thermo Fisher Scientific Inc.

Mast Group Ltd.

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the antimicrobial susceptibility testing market.

2. Complete coverage of all the segments in the antimicrobial susceptibility testing market to analyze the trends, developments in the global market, and forecast of market size up to 2030.

3. Comprehensive analysis of the companies operating in the global antimicrobial susceptibility testing market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand and/or diversify.